{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:12:08Z","timestamp":1781763128409,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.healun.2010.08.024","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T05:46:57Z","timestamp":1286171217000},"page":"188-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Impact of lung transplantation on serum lipids in adults with cystic fibrosis"],"prefix":"10.1016","volume":"30","author":[{"given":"Edward F.","family":"Nash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne G.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2010.08.024_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1054\/clnu.1999.0079","article-title":"Pathogenesis of malnutrition in cystic fibrosis, and its treatment","volume":"19","author":"Pencharz","year":"2000","journal-title":"Clin Nutr"},{"key":"10.1016\/j.healun.2010.08.024_bib2","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.jada.2007.09.005","article-title":"Nutrient status of adults with cystic fibrosis","volume":"107","author":"Gordon","year":"2007","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.healun.2010.08.024_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ajcn\/75.6.1005","article-title":"Abnormal lipid concentrations in cystic fibrosis","volume":"75","author":"Figueroa","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.healun.2010.08.024_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1203\/00006450-199308000-00011","article-title":"Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis","volume":"34","author":"Levy","year":"1993","journal-title":"Pediatr Res"},{"key":"10.1016\/j.healun.2010.08.024_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcf.2009.09.002","article-title":"Prevalence of dyslipidemia in adults with cystic fibrosis","volume":"9","author":"Rhodes","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.healun.2010.08.024_bib6","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2010.08.024_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2008.07.018","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart\/lung transplantation report\u20142008","volume":"27","author":"Christie","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.08.024_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3810\/pgm.2008.04.1759","article-title":"Management of dyslipidemia in patients after solid organ transplantation","volume":"120","author":"Tannock","year":"2008","journal-title":"Postgrad Med"},{"key":"10.1016\/j.healun.2010.08.024_bib9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.transproceed.2009.02.045","article-title":"Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients","volume":"41","author":"Sessa","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2010.08.024_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1432-2277.1998.tb00789.x","article-title":"Lipid abnormalities in stable liver transplant recipients\u2014effects of cyclosporine, tacrolimus and steroids","volume":"11","author":"Fern\u00e1ndez-Miranda","year":"1998","journal-title":"Transplant Int"},{"key":"10.1016\/j.healun.2010.08.024_bib11","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.transproceed.2006.08.070","article-title":"Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study","volume":"38","author":"Marc\u00e9n","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2010.08.024_bib12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.healun.2005.01.004","article-title":"New-onset cardiovascular risk factors in lung transplant recipients","volume":"24","author":"Silverborn","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.08.024_bib13","first-page":"913","article-title":"Canadian Cardiovascular Society position statement\u2014recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","volume":"22","author":"McPherson","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2010.08.024_bib14","doi-asserted-by":"crossref","first-page":"91G","DOI":"10.1016\/0002-9149(87)90165-2","article-title":"Coronary risk prediction in adults (the Framingham Heart Study)","volume":"59","author":"Wilson","year":"1987","journal-title":"Am J Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.healun.2010.08.024_bib15","first-page":"S83","article-title":"Management of dyslipidemia in adults with diabetes","volume":"26","author":"Haffner","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.healun.2010.08.024_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","article-title":"A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus","volume":"18","author":"Taylor","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.08.024_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1681\/ASN.V122368","article-title":"Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus","volume":"12","author":"Ligtenberg","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2010.08.024_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1600-6143.2004.00427.x","article-title":"Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile","volume":"4","author":"Artz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2010.08.024_bib19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.TP.0000157870.21957.E5","article-title":"Tacrolimus and posttransplant diabetes mellitus in renal transplantation","volume":"79","author":"van Hooff","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2010.08.024_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2466-6-9","article-title":"An adult cystic fibrosis patient presenting with persisting dyspnea: case report","volume":"8","author":"Onady","year":"2006","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.healun.2010.08.024_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1513\/pats.200808-077GO","article-title":"Medical complications of lung transplantation","volume":"6","author":"Lyu","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.healun.2010.08.024_bib22","first-page":"134","article-title":"Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease","volume":"13","author":"Huiart","year":"2006","journal-title":"Can Respir J"},{"key":"10.1016\/j.healun.2010.08.024_bib23","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMe048211","article-title":"Chronic kidney disease predicts cardiovascular disease","volume":"351","author":"Hostetter","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2010.08.024_bib24","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1111\/j.1600-6143.2007.01968.x","article-title":"Hyperlipidemia is associated with accelerated chronic kidney disease progression after lung transplantation","volume":"7","author":"Stephany","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2010.08.024_bib25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/rccm.200205-410OC","article-title":"Statin use is associated with improved function and survival in lung allografts","volume":"167","author":"Johnson","year":"2003","journal-title":"Am J Crit Care Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249810005322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249810005322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:22:15Z","timestamp":1760948535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249810005322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1053249810005322"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2010.08.024","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of lung transplantation on serum lipids in adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2010.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}